The present invention relates to an imidazopyridinamine phenyl derivative, pharmaceutically acceptable salt thereof, hydrate or metabolite formed by metabolizing in any form, and use thereof in the preparation of a medicament for preventing and/or treating indications associated with BTK function. The imidazopyridinamine phenyl derivative according to the present invention is an ideal high-efficiency BTK inhibitor for treating or preventing diseases such as rheumatoid arthritis, B-cell lymphoma, leukemia, multiple myeloma, allergies, asthma, multiple sclerosis, type I diabetes and systemic lupus erythematosus.
